AUPH's Quality Score fell 1 point on Mon, Nov 2, to 8. Its price fell below its average of the last 21 days (2 chart checks stopped).
Follow AUPH's trial news. Pro members can get an alert when Aurinia Pharmaceuticals files news, and see its trials, share raises, and its CEO's filings.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Down 3.1% today, more than its biotech peers' 2.4%; no story names it yet.
Beats the market
Up 37% in a year while the S&P 500 rose 12%.
| The company | Profit up 418% to $314M |
| Latest filing | 8-K, Oct 30 |
TodayNo story names it yet.
After its last 4 reports it closed -1.8% on average, higher 1 of 4 times.
No shelf registration or at-the-market program on file in the last three years.
Chief Legal Officer Stephen P. Robertson sold 11,939 shares on Sep 10. 3 more insider trades this year.
Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.
Averagefor quality, not price, 2 of 14 chart checks firingWhat the Quality Score means
AUPH is #47 of 291 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 47 |
Share count against a year before: AUPH -3.6%, MIRM +27%, XENE +26%, XNCR +2.1%.
Expected to report Mon Mar 1, before the open (in 119 days). Expected.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $83.7M, 14% more than a year ago; a profit of $0.23 a share, from $0.23.
AUPH's results filing gives no sales by line in a table we read. Its annual report gives the year's, in About.
| Measure | Figure |
|---|---|
| Total revenue | $325M to $330M |
Sales grew 41% a year over 5 years, fiscal 2020 to 2025.
Its share count grew 3.2% a year over 5 years.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Oct 30, 2026 | -2.6% | -3.3% | open |
| Aug 6, 2026 | +4.9% | +6.2% | +1.7% |
| May 7, 2026 | +0.3% | -6.8% | -1.3% |
Sales grew in five of the last seven years, to $283M in 2025. It made a profit in two of the eight years.
One insider bought $12.5M across 5 filings, and one insider sold $546K across 2 filings, in the last 6 months. The newest:
Officers and directors with a Form 4 in the last 12 months.
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
“The pharmaceutical industry is competitive.”
AUPH scores 8 today, which Breakaway calls Average. It is #47 of 291 in Biotech by Quality Score, with 2 of 14 chart checks firing. Up 37% in a year while the S&P 500 rose 12%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
AUPH scores 8 today, which Breakaway calls Average (6 to 10). That is #47 of 291 in Biotech by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind AUPH's 8.
One insider bought $12.5M across 5 filings, and one insider sold $546K across 2 filings, in the last 6 months. The newest is Stephen P. Robertson, Chief Legal Officer, who sold $190K on Sep 10. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.